Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.


GREY:IVITF - Post by User

Comment by display_nameon Feb 27, 2019 3:14pm
85 Views
Post# 29419467

RE:RE:RE:RE:Anybody know what the sale are

RE:RE:RE:RE:Anybody know what the sale are You should read their investor deck if you have the opportunity, they've done a pretty good job making their production plan transparent:

https://www.invictus-md.com/_resources/presentations/corporate-presentation.pdf

Right now they have ~189,000 sq.ft of capacity and their own estimate is 1000 kg of production /yr / 10,000 sq ft. Should put them at 18,900 kg of product per year.

I've been using two models to project their sales for my own personal use, one assuming 100% of inventory liquidated at spot price of $2/gram (VERY conservative estimate), this puts thema t 37.8 mil in sales.

The other I assume 60% spot liquidation @ $2, 20% medical wholesale liquidation @ $3 / gram, and 20% retail liquidation @ $4/gram. I am not sure what % allocation is accurate for them since they're vertically integrating with production/retail/medical and havent done a great job keeping that transparent - one complaint i do have - but I think this gets me close to reality. This puts them at 45.36 mil in sales.

As long as they hit somewhere between these numbers they're on track and doing jsut fine IMO
<< Previous
Bullboard Posts
Next >>